Search

everythinglearnresearchcommunity

for

Search:↓

People with early onset androgenetic alopecia may have a higher chance of metabolic syndrome, especially dyslipidemia.

Accurate early diagnosis of Lichen Planopilaris is crucial to prevent permanent hair loss.

A woman developed permanent hair loss after a face-lift surgery despite various treatments.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Treating hair loss effectively may require a multi-sided approach, using different treatments together, and topical treatments could be more effective and safer than oral ones.

The combination therapy of PEG-IFN α-2a and Ribavirin can cause widespread hair loss and skin reactions.

The 'Swiss cheese' pattern in scalp biopsies can indicate trichotillomania, not just alopecia areata.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

Using dermoscopy improves diagnosis of scalp and hair disorders in children.

The belief about hair shedding phases is likely incorrect and needs reevaluation.

Personalized treatments for hair loss are becoming more effective by using genetic information.

A new treatment using hybrid vesicles with gold nanoparticles and finasteride significantly improves hair regrowth for androgenetic alopecia.

Baricitinib effectively promotes hair regrowth in both scalp and nonscalp areas for alopecia areata universalis patients.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

RF-based therapies might help treat hair loss.

Fractional laser therapy is a promising, effective, and minimally invasive treatment for hair loss.

Heat-treated Limosilactobacillus fermentum with menthol, salicylic acid, and panthenol promotes hair growth and balances scalp microbiome in people with androgenetic alopecia.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

New microneedle treatment with growth factors and a hair loss drug shows better and faster hair growth results than current treatments.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Adding a zygomaticotemporal nerve block reduces pain more effectively during hair regrowth treatments.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Pilose antler extract helps hair grow in mice with a type of hair loss by speeding up the growth phase.

Trichoscopy shows hair diameter variability, vellus hairs, and the peripilar sign are key indicators for diagnosing Androgenetic Alopecia.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

Trichoscopy helps tell apart other hair loss conditions from common hair loss.